methylphenidate (Ritalin) might be carcinogenic

There are new concerns that methylphenidate (Ritalin) might be carcinogenic.

Ciba is putting new info in the package insert...and sending out a letter to physicians and pharmacists.

This is based on recent toxicology studies which show an increased incidence of liver tumours in some mice...but not in rats.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote